arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

COMPASS Pathways plc

CMPS
$7.81 ▼ -0.78 (-9.08%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
28 Visible periods
23 Metrics
Peer-ranked Benchmarks
Price Chart
54
Health
Fair
Bullish
auto_awesome

Analytical Summary

COMPASS Pathways plc shows strong fundamentals with top-quartile Debt to Equity. The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $1.1B
Dividend Yield —
Revenue Growth —
Op. Margin —
ROIC -26.3% ↗
FCF / Share $-0.37 ↘
Trailing P/E —
Price / Book 7.8x
FCF Yield —
Debt / Equity 0.36
info Valuation on last close. End-of-day price, Nov 5, 2026.

28-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Net Income Profit after all expenses
$91.20M
— 0.0% —
FCF / Share Free cash flow per share
$-0.37
↓ -22.6% —
Long-Term Debt Long-term obligations
$50.99M
↑ +0.5% —
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Financial Health ↑
60
Cash Quality ↓
42

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 8 years · 28 quarters